NCT01340521View on ClinicalTrials.gov

Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH) Response to Low Dose Clomiphene Citrate in Normally Menstruating Fertile Women

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

March 31, 1991

Primary Completion Date

March 31, 1994

Study Completion Date

March 31, 1994

Conditions
Infertility
Interventions
DRUG

Clomiphene Citrate

0, 25, 50 or 100 milligrams daily. Will be taken orally days five through nine of the menstrual cycle.

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Collaborators (1)

Mayo Clinic
All Listed Sponsors
collaborator

Mayo Clinic

OTHER

lead

Milton S. Hershey Medical Center

OTHER